These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 28463501)

  • 1. Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.
    Beldman TJ; Senders ML; Alaarg A; Pérez-Medina C; Tang J; Zhao Y; Fay F; Deichmöller J; Born B; Desclos E; van der Wel NN; Hoebe RA; Kohen F; Kartvelishvily E; Neeman M; Reiner T; Calcagno C; Fayad ZA; de Winther MPJ; Lutgens E; Mulder WJM; Kluza E
    ACS Nano; 2017 Jun; 11(6):5785-5799. PubMed ID: 28463501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles.
    Hossaini Nasr S; Rashidijahanabad Z; Ramadan S; Kauffman N; Parameswaran N; Zinn KR; Qian C; Arora R; Agnew D; Huang X
    Nanoscale; 2020 May; 12(17):9541-9556. PubMed ID: 32314997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid nanoparticles for active targeting atherosclerosis.
    Lee GY; Kim JH; Choi KY; Yoon HY; Kim K; Kwon IC; Choi K; Lee BH; Park JH; Kim IS
    Biomaterials; 2015; 53():341-8. PubMed ID: 25890732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy.
    Zhang M; He J; Jiang C; Zhang W; Yang Y; Wang Z; Liu J
    Int J Nanomedicine; 2017; 12():533-558. PubMed ID: 28144137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe.
    Ahmed M; Tegnebratt T; Tran TA; Lu L; Damberg P; Gisterå A; Tarnawski L; Bone D; Hedin U; Eriksson P; Holmin S; Gustafsson B; Caidahl K
    Int J Nanomedicine; 2020; 15():6137-6152. PubMed ID: 32884268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
    Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin.
    Cheraga N; Ye Z; Xu MJ; Zou L; Sun NC; Hang Y; Shan CJ; Yang ZZ; Chen LJ; Huang NP
    Nanoscale; 2022 Jun; 14(24):8709-8726. PubMed ID: 35673987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.
    Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J
    Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery.
    Yu M; Ortega CA; Si K; Molinaro R; Schoen FJ; Leitao RFC; Xu X; Mahmoudi M; Ahn S; Liu J; Saw PE; Lee IH; Brayner MMB; Lotfi A; Shi J; Libby P; Jon S; Farokhzad OC
    Theranostics; 2018; 8(21):6008-6024. PubMed ID: 30613278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cluster of Differentiation-44-Targeting Prussian Blue Nanoparticles Onloaded with Colchicine for Atherosclerotic Plaque Regression in a Mice Model.
    Zhu Y; Fang Y; Wang Y; Han D; Liu J; Tian L; Xu M; Wang Y; Cao F
    ACS Biomater Sci Eng; 2024 Mar; 10(3):1530-1543. PubMed ID: 38372216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
    Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle-Aided Characterization of Arterial Endothelial Architecture during Atherosclerosis Progression and Metabolic Therapy.
    Beldman TJ; Malinova TS; Desclos E; Grootemaat AE; Misiak ALS; van der Velden S; van Roomen CPAA; Beckers L; van Veen HA; Krawczyk PM; Hoebe RA; Sluimer JC; Neele AE; de Winther MPJ; van der Wel NN; Lutgens E; Mulder WJM; Huveneers S; Kluza E
    ACS Nano; 2019 Dec; 13(12):13759-13774. PubMed ID: 31268670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosis.
    Zhang XQ; Even-Or O; Xu X; van Rosmalen M; Lim L; Gadde S; Farokhzad OC; Fisher EA
    Adv Healthc Mater; 2015 Jan; 4(2):228-36. PubMed ID: 25156796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques.
    Majmudar MD; Yoo J; Keliher EJ; Truelove JJ; Iwamoto Y; Sena B; Dutta P; Borodovsky A; Fitzgerald K; Di Carli MF; Libby P; Anderson DG; Swirski FK; Weissleder R; Nahrendorf M
    Circ Res; 2013 Mar; 112(5):755-61. PubMed ID: 23300273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic Acid-Guided Cerasome Nano-Agents for Simultaneous Imaging and Treatment of Advanced Atherosclerosis.
    Ma Q; Wu S; Yang L; Wei Y; He C; Wang W; Zhao Y; Wang Z; Yang S; Shi D; Liu Y; Zhou Z; Sun J; Zhou Y
    Adv Sci (Weinh); 2023 Feb; 10(5):e2202416. PubMed ID: 36529695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine Tuning of Core-Shell Structure of Hyaluronic Acid/Cell-Penetrating Peptides/siRNA Nanoparticles for Enhanced Gene Delivery to Macrophages in Antiatherosclerotic Therapy.
    Zhao Y; He Z; Gao H; Tang H; He J; Guo Q; Zhang W; Liu J
    Biomacromolecules; 2018 Jul; 19(7):2944-2956. PubMed ID: 29641895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
    Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembled hyaluronic acid nanoparticles: Implications as a nanomedicine for treatment of type 2 diabetes.
    Rho JG; Han HS; Han JH; Lee H; Nguyen VQ; Lee WH; Kwon S; Heo S; Yoon J; Shin HH; Lee EY; Kang H; Yang S; Lee EK; Park JH; Kim W
    J Control Release; 2018 Jun; 279():89-98. PubMed ID: 29649530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phagocytosis of polymeric nanoparticles aided activation of macrophages to increase atherosclerotic plaques in ApoE
    Yin T; Li Y; Ren Y; Fuad ARM; Hu F; Du R; Wang Y; Wang G; Wang Y
    J Nanobiotechnology; 2021 Apr; 19(1):121. PubMed ID: 33910571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.